Scot A. Fahs

1.5k total citations
35 papers, 1.2k citations indexed

About

Scot A. Fahs is a scholar working on Hematology, Genetics and Surgery. According to data from OpenAlex, Scot A. Fahs has authored 35 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Hematology, 9 papers in Genetics and 8 papers in Surgery. Recurrent topics in Scot A. Fahs's work include Platelet Disorders and Treatments (26 papers), Hemophilia Treatment and Research (16 papers) and Blood groups and transfusion (12 papers). Scot A. Fahs is often cited by papers focused on Platelet Disorders and Treatments (26 papers), Hemophilia Treatment and Research (16 papers) and Blood groups and transfusion (12 papers). Scot A. Fahs collaborates with scholars based in United States, Ireland and China. Scot A. Fahs's co-authors include Robert R. Montgomery, Qizhen Shi, Sandra L. Haberichter, Erin L. Kuether, David A. Wilcox, Hartmut Weiler, Philip A. Kroner, Jocelyn A. Schroeder, Sachiko Kanaji and Brian C. Cooley and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Molecular Therapy.

In The Last Decade

Scot A. Fahs

34 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scot A. Fahs United States 19 844 330 287 206 200 35 1.2k
Colleen Notley Canada 22 1.1k 1.3× 368 1.1× 316 1.1× 162 0.8× 213 1.1× 39 1.5k
Qizhen Shi United States 23 1.2k 1.4× 629 1.9× 564 2.0× 492 2.4× 168 0.8× 78 1.8k
Takao Yoshihara Japan 17 347 0.4× 129 0.4× 306 1.1× 190 0.9× 217 1.1× 62 885
JM Crawford United States 6 505 0.6× 191 0.6× 243 0.8× 180 0.9× 562 2.8× 9 1.1k
Albertus W. Wognum Netherlands 14 318 0.4× 197 0.6× 309 1.1× 151 0.7× 175 0.9× 26 789
Judith S. Greengard United States 18 497 0.6× 218 0.7× 336 1.2× 54 0.3× 87 0.4× 26 976
Julian Topaly Germany 15 522 0.6× 133 0.4× 240 0.8× 194 0.9× 123 0.6× 31 848
Shunya Arai Japan 19 629 0.7× 96 0.3× 678 2.4× 183 0.9× 195 1.0× 51 1.3k
Magda Marcatti Italy 15 427 0.5× 118 0.4× 457 1.6× 516 2.5× 210 1.1× 55 967
Oscar Berlanga United Kingdom 16 453 0.5× 142 0.4× 213 0.7× 59 0.3× 213 1.1× 34 794

Countries citing papers authored by Scot A. Fahs

Since Specialization
Citations

This map shows the geographic impact of Scot A. Fahs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scot A. Fahs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scot A. Fahs more than expected).

Fields of papers citing papers by Scot A. Fahs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scot A. Fahs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scot A. Fahs. The network helps show where Scot A. Fahs may publish in the future.

Co-authorship network of co-authors of Scot A. Fahs

This figure shows the co-authorship network connecting the top 25 collaborators of Scot A. Fahs. A scholar is included among the top collaborators of Scot A. Fahs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scot A. Fahs. Scot A. Fahs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Qizhen, Scot A. Fahs, Patricia A. Morateck, et al.. (2022). A novel mouse model of type 2N VWD was developed by CRISPR/Cas9 gene editing and recapitulates human type 2N VWD. Blood Advances. 6(9). 2778–2790. 4 indexed citations
2.
Flood, Veronica H., Sandra L. Haberichter, Scot A. Fahs, et al.. (2019). A rat model of severe VWD by elimination of the VWF gene using CRISPR/Cas9. Research and Practice in Thrombosis and Haemostasis. 4(1). 64–71. 4 indexed citations
3.
Kanaji, Sachiko, Jennifer N. Orje, Taisuke Kanaji, et al.. (2018). Humanized GPIbα–von Willebrand factor interaction in the mouse. Blood Advances. 2(19). 2522–2532. 12 indexed citations
4.
5.
Kanaji, Sachiko, Scot A. Fahs, Jerry Ware, Robert R. Montgomery, & Qizhen Shi. (2014). Non‐myeloablative conditioning with busulfan before hematopoietic stem cell transplantation leads to phenotypic correction of murine Bernard‐Soulier syndrome. Journal of Thrombosis and Haemostasis. 12(10). 1726–1732. 3 indexed citations
6.
Kanaji, Sachiko, Scot A. Fahs, Qizhen Shi, Sandra L. Haberichter, & Robert R. Montgomery. (2012). Contribution of platelet vs. endothelial VWF to platelet adhesion and hemostasis. Journal of Thrombosis and Haemostasis. 10(8). 1646–1652. 102 indexed citations
7.
Shi, Qizhen, Erin L. Kuether, Jocelyn A. Schroeder, et al.. (2012). Factor VIII inhibitors: von Willebrand factor makes a difference in vitro and in vivo. Journal of Thrombosis and Haemostasis. 10(11). 2328–2337. 20 indexed citations
8.
Shi, Qizhen, Erin L. Kuether, Jocelyn A. Schroeder, Scot A. Fahs, & RR Montgomery. (2012). Intravascular recovery of VWF and FVIII following intraperitoneal injection and differences from intravenous and subcutaneous injection in mice. Haemophilia. 18(4). 639–646. 18 indexed citations
9.
Kuether, Erin L., Jocelyn A. Schroeder, Scot A. Fahs, et al.. (2012). Lentivirus‐mediated platelet gene therapy of murine hemophilia A with pre‐existing anti‐factor VIII immunity. Journal of Thrombosis and Haemostasis. 10(8). 1570–1580. 85 indexed citations
10.
Kanaji, Sachiko, Erin L. Kuether, Scot A. Fahs, et al.. (2011). Correction of Murine Bernard–Soulier Syndrome by Lentivirus-mediated Gene Therapy. Molecular Therapy. 20(3). 625–632. 21 indexed citations
11.
Shi, Qizhen, Erin L. Kuether, Brian C. Cooley, et al.. (2009). Sustained Phenotypic Correction of Murine Hemophilia A with Pre-Existing Anti-FVIII Immunity Using Lentivirus-Mediated Platelet-Specific FVIII Gene Transfer.. Blood. 114(22). 29–29. 2 indexed citations
12.
Shi, Qizhen, David A. Wilcox, Scot A. Fahs, et al.. (2007). Lentivirus‐mediated platelet‐derived factor VIII gene therapy in murine haemophilia A. Journal of Thrombosis and Haemostasis. 5(2). 352–361. 109 indexed citations
13.
Shi, Qizhen, David A. Wilcox, Patricia A. Morateck, et al.. (2004). Targeting platelet GPIbα transgene expression to human megakaryocytes and forming a complete complex with endogenous GPIbβ and GPIX. Journal of Thrombosis and Haemostasis. 2(11). 1989–1997. 23 indexed citations
14.
Olsen, Eva H. N., Elizabeth P. Merricks, Thomas Fischer, et al.. (2003). Comparative response of plasma VWF in dogs to up-regulation of VWF mRNA by interleukin-11 versus Weibel-Palade body release by desmopressin (DDAVP). Blood. 102(2). 436–441. 34 indexed citations
15.
Fahs, Scot A., Timothy C. Nichols, Dwight A. Bellinger, & RR Montgomery. (2003). Cloning and expression of full-length recombinant porcine von Willebrand factor. Journal of Thrombosis and Haemostasis. 1. OC277–OC277. 1 indexed citations
16.
Shi, Qizhen, David A. Wilcox, Scot A. Fahs, Philip A. Kroner, & Robert R. Montgomery. (2003). Expression of human factor VIII under control of the platelet-specific αIIb promoter in megakaryocytic cell line as well as storage together with VWF. Molecular Genetics and Metabolism. 79(1). 25–33. 45 indexed citations
17.
Rosenberg, Jonathan B., Sandra L. Haberichter, Philip A. Kroner, et al.. (2002). The role of the D1 domain of the von Willebrand factor propeptide in multimerization of VWF. Blood. 100(5). 1699–1706. 57 indexed citations
18.
Haberichter, Sandra L., Scot A. Fahs, & Robert R. Montgomery. (2000). Von Willebrand factor storage and multimerization: 2 independent intracellular processes. Blood. 96(5). 1808–1815. 63 indexed citations
19.
Morateck, Patricia A., Scot A. Fahs, David C. Warltier, Robert R. Montgomery, & Dermot Kenny. (1999). Cloning and Expression of Canine Glycoprotein Ibα. Thrombosis and Haemostasis. 82(10). 1327–1333. 6 indexed citations
20.
Kroner, Philip A., et al.. (1991). Abnormal binding of factor VIII is linked with the substitution of glutamine for arginine 91 in von Willebrand factor in a variant form of von Willebrand disease.. Journal of Biological Chemistry. 266(29). 19146–19149. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Colleen Notley Breakdown of academic impact, for papers by Qizhen Shi Breakdown of academic impact, for papers by Takao Yoshihara Breakdown of academic impact, for papers by JM Crawford Breakdown of academic impact, for papers by Albertus W. Wognum Breakdown of academic impact, for papers by Judith S. Greengard Breakdown of academic impact, for papers by Julian Topaly Breakdown of academic impact, for papers by Shunya Arai Breakdown of academic impact, for papers by Magda Marcatti Breakdown of academic impact, for papers by Oscar Berlanga
Rankless by CCL
2026